TPO and COVID-19: In addition to the seven consensus statements, the experts also considered and discussed TPO-RA treatment in two further patient populations but failed to reach a consensus: chronic ITP patients with mild/moderate COVID-19 and treatment of ITP patients in the first-line setting.